Pirfenidone axunio (previously Pirfenidone AET) 欧盟 - 挪威文 - EMA (European Medicines Agency)

pirfenidone axunio (previously pirfenidone aet)

axunio pharma gmbh - pirfenidone - idiopatisk lungefibrose - immunsuppressive - pirfenidone aet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Pirfenidone Sandoz 801 mg 挪威 - 挪威文 - Statens legemiddelverk

pirfenidone sandoz 801 mg

sandoz - københavn - pirfenidon - tablett, filmdrasjert - 801 mg

Pirfenidone Sandoz 267 mg 挪威 - 挪威文 - Statens legemiddelverk

pirfenidone sandoz 267 mg

sandoz - københavn - pirfenidon - tablett, filmdrasjert - 267 mg

Qdenga 欧盟 - 挪威文 - EMA (European Medicines Agency)

qdenga

takeda gmbh - dengue virus, serotype 2, expressing dengue virus, serotype 1, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 3, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 4, surface proteins, live, attenuated, dengue virus, serotype 2, live, attenuated - dengue - vaksiner - qdenga is indicated for the prevention of dengue disease in individuals from 4 years of age. the use of qdenga should be in accordance with official recommendations.

Pirfenidone Viatris 欧盟 - 挪威文 - EMA (European Medicines Agency)

pirfenidone viatris

viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunsuppressive - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Pirfenidone Newbury 267 mg 挪威 - 挪威文 - Statens legemiddelverk

pirfenidone newbury 267 mg

newbury pharmaceuticals ab - pirfenidon - tablett, filmdrasjert - 267 mg

Pirfenidone Newbury 801 mg 挪威 - 挪威文 - Statens legemiddelverk

pirfenidone newbury 801 mg

newbury pharmaceuticals ab - pirfenidon - tablett, filmdrasjert - 801 mg

Instanyl 欧盟 - 挪威文 - EMA (European Medicines Agency)

instanyl

takeda pharma a/s - fentanyl citrate - pain; cancer - analgetika - instanyl er indisert for behandling av gjennombrudd smerte hos voksne allerede mottar vedlikehold opioid terapi for kronisk kreft smerter. gjennombruddssmerter er en forbigående forverring av smerte som oppstår på bakgrunn av ellers kontrollert vedvarende smerte.  patients receiving maintenance opioid therapy are those who are taking at least 60 mg of oral morphine daily, at least 25 micrograms of transdermal fentanyl per hour, at least 30 mg oxycodone daily, at least 8 mg of oral hydromorphone daily or an equianalgesic dose of another opioid for a week or longer.

Cetirizin Bluefish 10 mg 挪威 - 挪威文 - Statens legemiddelverk

cetirizin bluefish 10 mg

bluefish pharmaceuticals ab - cetirizindihydroklorid - tablett, filmdrasjert - 10 mg

Malarone 250 mg / 100 mg 挪威 - 挪威文 - Statens legemiddelverk

malarone 250 mg / 100 mg

glaxosmithkline as - atovakvon / proguanilhydroklorid - tablett, filmdrasjert - 250 mg / 100 mg